Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON DR. REDDYS LAB BIOCON /
DR. REDDYS LAB
 
P/E (TTM) x 35.4 24.0 147.3% View Chart
P/BV x 4.0 3.8 103.2% View Chart
Dividend Yield % 0.2 0.7 27.0%  

Financials

 BIOCON    DR. REDDYS LAB
EQUITY SHARE DATA
    BIOCON
Mar-22
DR. REDDYS LAB
Mar-22
BIOCON /
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs4245,614 7.6%   
Low Rs3153,655 8.6%   
Sales per share (Unadj.) Rs68.21,294.6 5.3%  
Earnings per share (Unadj.) Rs8.2126.9 6.4%  
Cash flow per share (Unadj.) Rs14.9196.9 7.6%  
Dividends per share (Unadj.) Rs0.5030.00 1.7%  
Avg Dividend yield %0.10.6 20.9%  
Book value per share (Unadj.) Rs68.51,145.8 6.0%  
Shares outstanding (eoy) m1,200.60166.43 721.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.43.6 151.4%   
Avg P/E ratio x45.336.5 124.2%  
P/CF ratio (eoy) x24.723.5 105.2%  
Price / Book Value ratio x5.44.0 133.3%  
Dividend payout %6.123.6 26.0%   
Avg Mkt Cap Rs m443,622771,272 57.5%   
No. of employees `000NANA-   
Total wages/salary Rs m18,80138,858 48.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m81,840215,452 38.0%  
Other income Rs m6,8914,847 142.2%   
Total revenues Rs m88,731220,299 40.3%   
Gross profit Rs m13,82737,674 36.7%  
Depreciation Rs m8,14211,652 69.9%   
Interest Rs m676958 70.6%   
Profit before tax Rs m11,90029,911 39.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1158,789 24.1%   
Profit after tax Rs m9,78521,122 46.3%  
Gross profit margin %16.917.5 96.6%  
Effective tax rate %17.829.4 60.5%   
Net profit margin %12.09.8 122.0%  
BALANCE SHEET DATA
Current assets Rs m83,823177,880 47.1%   
Current liabilities Rs m38,28097,658 39.2%   
Net working cap to sales %55.637.2 149.5%  
Current ratio x2.21.8 120.2%  
Inventory Days Days10156 180.6%  
Debtors Days Days92113 81.2%  
Net fixed assets Rs m117,184106,819 109.7%   
Share capital Rs m6,003832 721.5%   
"Free" reserves Rs m76,281189,859 40.2%   
Net worth Rs m82,284190,691 43.2%   
Long term debt Rs m39,9855,746 695.9%   
Total assets Rs m201,007284,699 70.6%  
Interest coverage x18.632.2 57.7%   
Debt to equity ratio x0.50 1,612.7%  
Sales to assets ratio x0.40.8 53.8%   
Return on assets %5.27.8 67.1%  
Return on equity %11.911.1 107.4%  
Return on capital %10.315.7 65.5%  
Exports to sales %047.1 0.0%   
Imports to sales %7.818.8 41.4%   
Exports (fob) Rs mNA101,544 0.0%   
Imports (cif) Rs m6,36040,401 15.7%   
Fx inflow Rs m8,885101,544 8.7%   
Fx outflow Rs m6,36040,401 15.7%   
Net fx Rs m2,52561,143 4.1%   
CASH FLOW
From Operations Rs m11,76628,108 41.9%  
From Investments Rs m-16,991-26,387 64.4%  
From Financial Activity Rs m2,421-2,422 -100.0%  
Net Cashflow Rs m-2,43332 -7,603.1%  

Share Holding

Indian Promoters % 39.7 26.7 148.5%  
Foreign collaborators % 21.0 0.0 -  
Indian inst/Mut Fund % 23.6 51.0 46.2%  
FIIs % 15.8 26.3 60.1%  
ADR/GDR % 0.0 10.1 -  
Free float % 39.4 63.2 62.3%  
Shareholders   369,816 259,271 142.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   CIPLA    SUN PHARMA    AUROBINDO PHARMA    LUPIN    ZYDUS LIFESCIENCES    


More on Biocon vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs Dr. Reddys Share Price Performance

Period Biocon Dr. Reddys S&P BSE HEALTHCARE
1-Day -1.23% 1.21% 0.15%
1-Month -2.31% -2.92% -1.70%
1-Year -26.96% -4.19% -6.84%
3-Year CAGR -2.02% 14.86% 20.62%
5-Year CAGR -12.28% 14.98% 10.61%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.1%.

Dr. Reddys paid Rs 30.0, and its dividend payout ratio stood at 23.6%.

You may visit here to review the dividend history of Biocon, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 389 Points | Nifty Today Ends Below 18,500 | IT Stocks Witness Selling Pressure(Closing)

After opening the day on a flat note, Indian shares reversed early gains to end the day 0.6% lower.